Table:
begin	end	state
1	11	cytoplasmic
12	30	transmembrane
31	49	non-cytoplasmic
50	69	transmembrane
70	80	cytoplasmic
81	101	transmembrane
102	106	non-cytoplasmic
107	130	transmembrane
131	141	cytoplasmic
142	162	transmembrane
163	173	non-cytoplasmic
174	196	transmembrane
197	239	cytoplasmic
240	262	transmembrane
263	273	non-cytoplasmic
274	297	transmembrane
298	308	cytoplasmic
309	327	transmembrane
328	332	non-cytoplasmic
333	352	transmembrane
353	361	cytoplasmic
362	385	transmembrane
386	396	non-cytoplasmic
397	417	transmembrane
418	431	cytoplasmic

Input:
>PfGW456L13_3929
MKTLPAPLLAKISWRLLPFLLLMYIMAFLDRANVGFAKQAFQADTNISDAAFAFGAGVFF
VGYALLEVPSNLILHRVGARLWMCRIMVTWGLVSAAMVFAHTETSFYILRFLLGVAEAGF
FPGVILYLTYWFPSAVRGKAMGFFYFGAPLAFIFGSPLSGLLLELDGFAGFHGWQWLFAV
EGLMATAVGIWAYWYLDNRPADAKWLTVEERQQVQSLLNQEDSHKQNHGRSLLNVICQPS
VLYLCLIYLLIQASVYGVVFYLPSQVGGLLGTKVGLMVGLVTAIPWICALIAAYLIPGYS
DRTGERRRTACLTLLMAAAGIACSVTFSNPLLGIIALCFAASGFIAVQPVFWTFPSSYLA
GSAAAAGIALINSFGALGGFIAPVLKNWAEGAFHSPAAGLYVLAATTVIAALLVLGIRAP
GHKASNKPATV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server